Week Ending November 19, 2018
The American Lung Association’s LUNG FORCE Initiative Launches New Campaign, ‘Lock Up Lung Cancer,’ to Expose Hidden Killer of Women
“If a serial killer were as prolific as lung cancer at taking the lives of women, it would be Public Enemy #1.”
Targeted Lung Cancer Therapy
“A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer.”
Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries
“Survival rates of lung cancer remains poor and the impact of comorbidities on the prognosis is discussed. The objective of this study was to assess if the Charlson Comorbidity Index (CCI) was associated with 8-year survival rates by histological type.”
Can Exercise Offer Benefit in Advanced Lung Cancer Patients?
“Good adherence to a regular exercise program can improve levels of fatigue and functional well-being among patients with advanced inoperable lung cancer, according to a new study. In spite of that, a second study shows that many lung cancer patients are unaware of the potential benefits of exercise.”
Combination of two immunotherapies shows activity in non-small cell lung cancer patients
“A combination of two drugs, which prompt the body’s immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small cell lung cancer and has shown some signs of efficacy.”
Researchers identify a mechanism that fuels cancer cells’ growth
“Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.”
Recent News
Week Ending November 19, 2018
The American Lung Association’s LUNG FORCE Initiative Launches New Campaign, ‘Lock Up Lung Cancer,’ to Expose Hidden Killer of Women
“If a serial killer were as prolific as lung cancer at taking the lives of women, it would be Public Enemy #1.”
Targeted Lung Cancer Therapy
“A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer.”
Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries
“Survival rates of lung cancer remains poor and the impact of comorbidities on the prognosis is discussed. The objective of this study was to assess if the Charlson Comorbidity Index (CCI) was associated with 8-year survival rates by histological type.”
Can Exercise Offer Benefit in Advanced Lung Cancer Patients?
“Good adherence to a regular exercise program can improve levels of fatigue and functional well-being among patients with advanced inoperable lung cancer, according to a new study. In spite of that, a second study shows that many lung cancer patients are unaware of the potential benefits of exercise.”
Combination of two immunotherapies shows activity in non-small cell lung cancer patients
“A combination of two drugs, which prompt the body’s immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small cell lung cancer and has shown some signs of efficacy.”
Researchers identify a mechanism that fuels cancer cells’ growth
“Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.”
VIDEOS
Dr. Herbst on Immune Resistance in Lung Cancer
By using overflow:auto, the box will only grow scrollbars if the contents are too big to fit inside. In other words, scrollbars will only appear when they’re needed.
To demonstrate this, the following boxes use exactly the same code to define the scrollbox. The only difference between the two, is the size of their contents. The first box only has one small line of text, whereas, the second box has many lines of text – too many to fit inside the box. Therefore, the second box displays scrollbars and the first box doesn’t.